Top 5 Stock To Trade Today 28 April 2021 | Capital Street Fx

Top 5 Stock

Top 5 Stock To Trade Today 28 April 2021 | Capital Street Fx

1. Boeing: – Boeing (NYSE:BA) reported on Wednesday first quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.

Boeing announced earnings per share of $-1.53 on revenue of $15.22B. Analysts polled by Investing.com anticipated EPS of $-0.9691 on revenue of $15.46B.

Boeing shares are up 13% from the beginning of the year, still down 12.87% from its 52 week high of $278.27 set on March 15. They are outperforming the S&P 500 which is up 11.47% from the start of the year.

2. GSK: – GSK topped analysts’ expectations for first-quarter earnings as more people visited clinics for critical treatments such as HIV and routine shots once COVID-19 curbs eased, adding on Wednesday that plans to split into two were “well underway”.

Turnover for the three months to March fell 15% to 7.42 billion pounds ($10.28 billion) at constant currency rates, while adjusted earnings stood at 22.9 pence per share, GSK, the world’s biggest vaccine maker by sales, said.

Analysts had expected adjusted earnings of 21.9 pence per share and sales of 7.83 billion pounds, a company-compiled consensus

 3. Alphabet : – Alphabet (NASDAQ:GOOGL) shares were up more than 5% in Wednesday’s premarket as its March quarter earnings showed that big budget spending on advertising is coming back.

The tech giant displayed all-round performance in the last quarter with its flagship Google search, YouTube and Google cloud registering healthy gains in revenue as people, many stuck at home by repeated lockdowns, gorged on gaming, music, sports and entertainment.  

The announcement of a $50 billion share repurchase program was also helping the bounce in shares.  

The company posted a 34% gain in revenue to $55.31 billion. Operating margin, a sign of profitability, rose a huge 1100 basis points to 30%.

4. CME GROUP: – Futures exchange operator CME Group Inc (NASDAQ:CME) reported a 25% drop in first-quarter profit, hurt by a decline in sales of some of its top products as pandemic-related stimulus from the U.S. government curbed hedging demand.

The Chicago-based company said on Wednesday its net profit for the three months ended March 31 stood at $574.4 million, or $1.60 per share, down from $766.2 million, or $2.14 per share, a year earlier. 

5. MOODY’s: – Moody’s reported on Wednesday first quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Moody’s announced earnings per share of $4.06 on revenue of $1.60B. Analysts polled by Investing.com anticipated EPS of $2.81 on revenue of $1.43B.

Moody’s shares are up 7.46% from the beginning of the year, still down 0.80% from its 52 week high of $329.03 set on April 22. They are under-performing the S&P 500 which is up 11.47% from the start of the year.

About Author

Related posts

Oxford Biomedica lifts outlook as AstraZeneca ramps up vaccine output

AstraZeneca (NASDAQ:AZN) UP 0.62% AT 7944 Oxford Biomedica on Tuesday doubled the revenue expectation from its COVID-19 vaccine supply deal with AstraZeneca (NASDAQ:AZN) after the drug maker commissioned more batches from the company in the second half of 2021. Shares of the cell therapy firm, which has an agreement...

Read More

Leave a Reply